Insulin and its analogues may function as growth factors and therefore have a theoretical potential to promote tumor proliferation through various mechanisms involving activation of the insulin receptor, IGF-1 receptor (IGF-1R) and extracellular-signaling-regulated kinase (ERK) pathways [261]. This evidence concerns the gene IGF1R and neoplasm.